bpc-157 dosage typical dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved bpc-157 dosage in ml bpc-157
Description
References Clark, J

This causes the Eustachian tube, which helps equalize pressure in the ears, to repeatedly open and close

Eye health may also benefit from Vitamin B12
(2003) NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells
